Citation 78944

NAGAYA,H: TOBITA,Y: NAGAE,T: ITOKAWA,H: TAKEYA,K: HALIM,AF: ABDEL-HALIM,OB:. (1997). CYTOTOXIC TRITERPENES FROM CLEOME AFRICANA.. 44(6)

Citation Details

Title	CYTOTOXIC TRITERPENES FROM CLEOME AFRICANA.
Authors	NAGAYA,H: TOBITA,Y: NAGAE,T: ITOKAWA,H: TAKEYA,K: HALIM,AF: ABDEL-HALIM,OB:
Year	1997
Volume	44
Issue	6

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Cleome africana (CAPPARIDACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CABRALEALACTONE,17-ALPHA-HYDROXY:	None
2	ANTIINFLAMMATORY ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
3	ANTIINFLAMMATORY ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CABRALEALACTONE,17-ALPHA-HYDROXY:	WEAK ACTIVITY
6	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CABRALEA-HYDROXYLACTONE,3-O-ACETYL-12-BETA-ACETOXY-17-ALPHA-HYDROXY:	None
7	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CABRALEA-HYDROXYLACTONE,17-ALPHA-HYDROXY:	None
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CABRALEA-HYDROXYLACTONE,3-O-ACETYL-12-BETA-ACETOXY-17-ALPHA-HYDROXY:	WEAK ACTIVITY
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CABRALEA-HYDROXYLACTONE,17-ALPHA-HYDROXY:	ACTIVE
10	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CLEOCARPONE,3-O-ACETYL-12-BETA-ACETOXY-25-O-ETHYL:	None
11	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CLEOCARPONE,12-BETA-ACETOXY:	None
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEOCARPONE,3-O-ACETYL-12-BETA-ACETOXY-25-O-ETHYL:	ACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEOCARPONE,12-BETA-ACETOXY:	WEAK ACTIVITY
14	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CLEOCARPANOL,12-BETA-ACETOXY:	None
15	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CLEOCARPANOL,3-O-ACETYL-12-BETA-HYDROXY:	None
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEOCARPANOL,12-BETA-ACETOXY:	WEAK ACTIVITY
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEOCARPANOL,3-O-ACETYL-12-BETA-HYDROXY:	WEAK ACTIVITY
18	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CABRALEALACTONE,22(23)-TETRADEHYDRO:	None
19	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	CABRALEALACTONE,1-2-DEHYDRO:	None
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CABRALEALACTONE,22(23)-TETRADEHYDRO:	ACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CABRALEALACTONE,1-2-DEHYDRO:	ACTIVE
22	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CABRALEALACTONE,1(2)-22(23)-TETRADEHYDRO: 12-BETA-ACETOXY:	None
23	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CABRALEALACTONE,1-2-DEHYDRO: 12-BETA-ACETOXY:	None
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CABRALEALACTONE,1(2)-22(23)-TETRADEHYDRO: 12-BETA-ACETOXY:	WEAK ACTIVITY
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CABRALEALACTONE,1-2-DEHYDRO: 12-BETA-ACETOXY:	WEAK ACTIVITY
26	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CLEOME TRITERPENE 16	None
27	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CLEOME TRITERPENE 17	None
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEOME TRITERPENE 16	WEAK ACTIVITY
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEOME TRITERPENE 17	WEAK ACTIVITY
30	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CABRALEALACTONE	None
31	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CLEOCARPONE	None
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CABRALEALACTONE	ACTIVE
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEOCARPONE	WEAK ACTIVITY
34	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CLEOCARPANOL	None
35	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	DAMMARAN-3-ALPHA-17-ALPHA-25-TRIOL,20(S)-24(R)-EPOXY:	None
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEOCARPANOL	WEAK ACTIVITY
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAMMARAN-3-ALPHA-17-ALPHA-25-TRIOL,20(S)-24(R)-EPOXY:	WEAK ACTIVITY
38	Not specified	CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CLEOME TRITERPENE 18	None
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLEOME TRITERPENE 18	WEAK ACTIVITY

Citation 78944

Citation Details

Summary

Organisms and Their Experiments (1)

Cleome africana (CAPPARIDACEAE)

Show SPARQL Queries (1)

Query 1